From antibiotics to storage, the system will change; new rules will apply to medicines.
- bySherya
- 20 Nov, 2026
The central government is preparing to increase oversight of everything from the manufacturing of antibiotics to the storage and supply of medicines. What impact will the new regulations have on pharmaceutical companies and patients?
New rules for antibiotics
In response to the growing problem of misuse and diminished effectiveness of antibiotics and other antimicrobial drugs, the central government is considering amending drug regulations. The Ministry of Health has clarified that the proposal to include antimicrobial drugs in the definition of "new drug" in the New Drugs and Clinical Trials Rules, 2019, will only affect new licenses issued in the future.
According to the ministry, companies that already have licenses to manufacture drugs will remain valid. Such companies will not need to re-apply for permission under the new proposal. The government aims to further strengthen regulations governing the manufacture of new antimicrobial drugs. This will ensure proper testing of the quality, safety, and efficacy of drugs before granting new manufacturing permission.
The quality of medicines will remain intact till they reach the patient.
The central government is taking a new step to ensure the quality and safety of medicines. Strict monitoring is now underway to ensure the packaging, storage, and delivery of medicines from the pharmaceutical manufacturing company to the patient.
The government proposed changes.
The Union Ministry of Health and Family Welfare has proposed changes to the Drugs Rules, 1945. Under this, Good Storage and Distribution Practices (GSDP) rules will be included for the proper storage and distribution of medicines.
The purpose of these regulations is to ensure that the quality, safety, and efficacy of medicines are not compromised from the moment they leave the factory until they reach the patient. The proposed regulations will cover the procurement, storage, supply, transportation, and record-keeping of medicines. This means that it will be necessary to maintain a complete record of where the medicine was purchased, where it was stored, and where it was shipped.
Why do medicines get spoiled?
Medicines can often be damaged after manufacturing due to improper storage or transportation. Failure to maintain temperature and other necessary conditions can compromise the quality of the medicine. Furthermore, there is a risk of problems such as adulteration, the supply of counterfeit medicines, drug exchange, and illegal sale. The new regulations will help curb these problems. Responsibilities will also be established for pharmaceutical companies, importers, wholesalers, distributors, and stockists.
These problems will be solved.
Implementing these rules will make it easier for the central and state drug control departments to monitor the storage and supply of medicines. Records can be used to trace where a medicine originated and where it was delivered, if necessary. The Health Ministry states that maintaining drug quality is essential not only during its production in the factory but also until it reaches the patient. This proposal will help make the drug supply system in the country more secure and accountable.



